The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification

About this update from Precision Peptide Company Inc

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations, today announced it has been awarded LegitScript Healthcare Merchant Certification - an independent, third-party seal recognizing the Company's compliance, transparency, and consumer-safety standards. The certification is recognized by Visa, Mastercard, Google, Microsoft, and Meta, many of which require it before a healthcare business can process payments or advertise on their platforms. For the Company, it unlocks broader access to these payment and advertising channels and strengthens its e-commerce growth strategy. Pratap Sandhu, CEO of The Precision Peptide Company, commented: "This certification reflects our commitment to operating to the highest standards of compliance and transparency, and is another milestone in the right direction for the Company. It builds trust with our customers and partners and positions us to scale responsibly across the major payment and advertising platforms." About LegitScript LegitScript blends cutting-edge AI, expert human insight, and unmatched market intelligence to help businesses anticipate threats and maintain compliance without slowing growth. Find out more: https://www.legitscript.com/ About The Precision Peptide Company The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the Company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America. For more information, visit: www.precisionpeptidecompany.com Company ContactPratap Sandhu CEO, Corporate Secretary and [email protected]+1 (604) 765-8069 Cautionary Note Regarding Forward-Looking Information This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation, including, without limitation, statements regarding the anticipated benefits of the Company's LegitScript Healthcare Merchant Certification, such as broade...

View stock analysis, news, and events for Precision Peptide Company Inc